Higano CS - Search Results

1

Management of bone loss in men with prostate cancer.

Higano CS. Higano CS. J Urol. 2003 Dec;170(6 Pt 2):S59-63; discussion S64. doi: 10.1097/01.ju.0000097351.48848.1f. J Urol. 2003. PMID: 14610412 Review.

2

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.

Higano CS. Higano CS. Urology. 2003 Feb;61(2 Suppl 1):32-8. doi: 10.1016/s0090-4295(02)02397-x. Urology. 2003. PMID: 12667885 Review.

3

The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

Cherrier MM, Rose AL, Higano C. Cherrier MM, et al. J Urol. 2003 Nov;170(5):1808-11. doi: 10.1097/01.ju.0000091640.59812.83. J Urol. 2003. PMID: 14532781 Clinical Trial.

4

Bone loss and the evolving role of bisphosphonate therapy in prostate cancer.

Higano CS. Higano CS. Urol Oncol. 2003 Sep-Oct;21(5):392-8. doi: 10.1016/s1078-1439(03)00143-1. Urol Oncol. 2003. PMID: 14670551 Review.

5

Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.

Higano CS, Vogelzang NJ, Sosman JA, Feng A, Caron D, Small EJ. Higano CS, et al. Clin Cancer Res. 2004 Feb 15;10(4):1219-25. doi: 10.1158/1078-0432.ccr-1404-02. Clin Cancer Res. 2004. PMID: 14977818 Clinical Trial.

6

Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.

Higano CS. Higano CS. Urol Clin North Am. 2004 May;31(2):331-52. doi: 10.1016/j.ucl.2004.01.001. Urol Clin North Am. 2004. PMID: 15123412 Review.

7

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Among authors: higano cs. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

8

Current status of treatment for patients with metastatic prostate cancer.

Higano CS. Higano CS. Can J Urol. 2005 Jun;12 Suppl 2:38-41. Can J Urol. 2005. PMID: 16018832 Review.

9

Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?

Higano CS. Higano CS. Nat Clin Pract Urol. 2008 Jan;5(1):24-34. doi: 10.1038/ncpuro0995. Nat Clin Pract Urol. 2008. PMID: 18185511 Review.

10

Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.

Higano CS, Quick DP, Bushnell D, Sartor O. Higano CS, et al. Clin Genitourin Cancer. 2008 Mar;6(1):40-5. doi: 10.3816/CGC.2008.n.007. Clin Genitourin Cancer. 2008. PMID: 18501082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters